Feedback (LON:FDBK) Hits New 1-Year Low – What’s Next?

Feedback plc (LON:FDBKGet Free Report)’s share price hit a new 52-week low during trading on Monday . The company traded as low as GBX 7.30 and last traded at GBX 7.40, with a volume of 26954 shares changing hands. The stock had previously closed at GBX 7.30.

Feedback Trading Up 1.4%

The business has a fifty day moving average of GBX 10.17 and a 200 day moving average of GBX 10.60. The company has a market capitalization of £3.24 million, a PE ratio of -0.47 and a beta of 0.77.

About Feedback

(Get Free Report)

Feedback plc (AIM: FDBK) provides innovative software and systems through its trading subsidiary, Feedback Medical.

Feedback liberates data and knowledge from multiple healthcare IT systems and delivers better workflows to enable clinicians to communicate, collaborate and provide the best healthcare for their patients. It connects care settings with diagnostic and other relevant data to drive better, faster, safer decision that improve outcomes for patients.

By linking different clinical systems together into a seamless view of the patient, Feedback can streamline patient pathways and deliver a digital health and diagnostics record across multiple care providers.

Bleepa® is a communication and collaboration platform that displays clinical results at a certified and regulated quality, which enables multi-disciplinary team working and diagnostic-enhanced advice and guidance.

See Also

Receive News & Ratings for Feedback Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Feedback and related companies with MarketBeat.com's FREE daily email newsletter.